Technical Analysis for IPCI - Intellipharmaceutics International Inc.

Grade Last Price % Change Price Change
grade F 0.2106 -22.00% -0.06
IPCI closed down 22.0 percent on Wednesday, March 20, 2019, on 1.93 times normal volume.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Down Down
See historical IPCI trend table...

Date Alert Name Type % Chg
Mar 20 Wide Bands Range Expansion 0.00%
Mar 19 Bearish Engulfing Bearish -22.00%
Mar 19 Non-ADX 1,2,3,4 Bearish Bearish Swing Setup -22.00%
Mar 19 Narrow Range Bar Range Contraction -22.00%
Mar 19 Inside Day Range Contraction -22.00%
Mar 19 Wide Bands Range Expansion -22.00%
Mar 18 Non-ADX 1,2,3,4 Bearish Bearish Swing Setup -23.42%
Mar 18 Wide Bands Range Expansion -23.42%
Mar 15 Inside Day Range Contraction -16.79%
Mar 15 Wide Bands Range Expansion -16.79%

Older signals for IPCI ...

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Intellipharmaceutics International Inc. engages in the research, development, and manufacture of novel and generic controlled and targeted release oral solid dosage drugs in Canada. It has a pipeline of products based on its patented Hypermatrix technology in various stages of development in therapeutic areas, including neurology, cardiovascular, gastrointestinal tract, and pain. The company's products under FDA review include Focalin XR, an extended release capsule for hyperactivity disorder; Effexor XR, an extended release capsule for depression; Protonix, a tablet for gastroesophageal reflux disease; Glucophage XR, a tablet for managing type 2 diabetes; Seroquel XR, a tablet for the treatment of schizophrenia, bipolar disorder, and depressive disorder; Lamictal XR, a tablet for anti-convulsant for epilepsy; and Keppra XR, a tablet for the treatment of partial onset seizures for epilepsy, as well as product filed with the FDA comprise Pristiq, a tablet for depression. The company has a license and commercialization agreement with Par Pharmaceutical, Inc. for the development and commercialization of generic Focalin XR. Its late stage development product includes Coreg CR, a capsule for heart failure and hypertension; and phase I clinical trial products include Lyrica, a capsule for Neuropathic pain and Oxycodone Hydrochloride, a controlled release capsule for pain. The company's non-generic products under development include Rexista, an oral formulation for pain relief, and Pregabalin, an extended release capsule for neuropathic pain. The company was founded in 1998 and is based in Toronto, Canada.
Chemistry Pain Diabetes Pharmacology Schizophrenia Euphoriants Hypertension Epilepsy FDA Heart Failure Depression Neurochemistry Bipolar Disorder Depressive Disorder Anticonvulsants Clinical Trial Products Gastroesophageal Reflux Disease Hyperactivity Disorder Mood Stabilizers Quetiapine
Is IPCI a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicator Value
52 Week High 6.6
52 Week Low 0.2
Average Volume 1,187,093
200-Day Moving Average 1.7691
50-Day Moving Average 0.3053
20-Day Moving Average 0.2836
10-Day Moving Average 0.25
Average True Range 0.0375
ADX 14.03
+DI 19.2629
-DI 28.8754
Chandelier Exit (Long, 3 ATRs ) 0.3175
Chandelier Exit (Short, 3 ATRs ) 0.3225
Upper Bollinger Band 0.3785
Lower Bollinger Band 0.1887
Percent B (%b) 0.12
BandWidth 66.925247
MACD Line -0.0215
MACD Signal Line -0.0186
MACD Histogram -0.0029
Fundamentals Value
Market Cap 6.54 Million
Num Shares 31.1 Million
EPS -0.34
Price-to-Earnings (P/E) Ratio -0.62
Price-to-Sales 5.78
Price-to-Book 0.00
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.30
Resistance 3 (R3) 0.31 0.29 0.28
Resistance 2 (R2) 0.29 0.26 0.28 0.28
Resistance 1 (R1) 0.25 0.25 0.24 0.24 0.27
Pivot Point 0.23 0.23 0.22 0.22 0.23
Support 1 (S1) 0.19 0.21 0.18 0.18 0.15
Support 2 (S2) 0.17 0.19 0.17 0.14
Support 3 (S3) 0.13 0.17 0.14
Support 4 (S4) 0.13